Nuvalent director granted 3,444 RSUs in stock award

Nuvalent, Inc. director Michael L. Meyers reported an equity grant of 3,444 shares of Class A Common Stock through restricted stock units (RSUs) at no cash cost.

Rhea-AI Filing Summary

Nuvalent, Inc. director Michael L. Meyers reported an equity grant of 3,444 shares of Class A Common Stock through restricted stock units (RSUs) at no cash cost. Each RSU converts into one share and vests in full on the earlier of June 16, 2027 or Nuvalent’s next annual stockholder meeting, subject to his continued service. Following this award, he holds 8,590 shares directly.

Insider Trade Summary

Grant/Award: 3,444 shares

Grant/Award 1 txn

Insider Meyers Michael L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,444	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 8,590 shares (Direct)

Footnotes (1)

1. F1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Key Figures

RSU grant size: 3,444 shares Grant price per RSU: $0.00 per share Shares after transaction: 8,590 shares +1 more

4 metrics

RSU grant size 3,444 shares Restricted stock units awarded on June 16, 2026

Grant price per RSU $0.00 per share Equity compensation award, no cash paid

Shares after transaction 8,590 shares Total Class A Common Stock beneficially owned following grant

RSU vesting date June 16, 2027 Vests earlier of this date or next annual meeting

Key Terms

restricted stock units ("RSUs"), vest in full, Class A Common Stock, annual meeting of stockholders, +1 more

5 terms

restricted stock units ("RSUs") financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders,"

Class A Common Stock financial

"Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs")."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

annual meeting of stockholders financial

"on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders,"

continued service financial

"subject to continued service to Nuvalent, Inc. through the applicable vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Michael L. Meyers report at Nuvalent (NUVL)?

Michael L. Meyers reported an award of 3,444 restricted stock units in Nuvalent Class A Common Stock. These RSUs are a compensation-related equity grant, not an open-market purchase, and increase his direct holdings to 8,590 shares after the reported transaction.

How many Nuvalent (NUVL) shares does Michael L. Meyers hold after this Form 4?

After the reported RSU grant, Michael L. Meyers beneficially owns 8,590 shares of Nuvalent Class A Common Stock. This figure includes the newly awarded 3,444 restricted stock units that will settle into shares upon vesting, assuming continued service through the vesting date.

When do Michael L. Meyers’s new Nuvalent (NUVL) RSUs vest?

The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent’s next annual meeting of stockholders. Vesting is conditioned on Michael L. Meyers continuing to provide service to Nuvalent through the applicable vesting date described in the award terms.

Did Michael L. Meyers buy Nuvalent (NUVL) shares on the market in this filing?

No, the Form 4 reports a grant of 3,444 restricted stock units at a price of $0.00 per unit. This is a stock-based compensation award, not an open-market purchase or sale, and therefore does not reflect a cash trade in Nuvalent shares.

What type of security was granted to Michael L. Meyers by Nuvalent (NUVL)?

Nuvalent granted Michael L. Meyers restricted stock units, each representing the right to receive one share of Class A Common Stock. These RSUs provide share-based compensation that converts into actual stock when vesting conditions tied to time and service are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meyers Michael L.

(Last) (First) (Middle)

C/O NUVALENT, INC.

ONE BROADWAY, 14TH FLOOR

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/16/2026		A		3,444(1)	A	$0.00	8,590	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 16, 2027 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

	/s/ Nathan N. McConarty, attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)